Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
A new study found that dementia cases in the United States are projected to double from more than 500,000 in 2020 to about 1 million by 2050.
Ozempic Could Help Reduce Alzheimer’s Risk For Some, Study Suggests: ‘Shifting The Paradigm’ Stanford also warned that ...
My weight concerns mainly injure my considerable vanity, and I’m not about to outsource my self-esteem issue to Big Pharma if ...
SEE ALSO | Lifestyle changes are key after study links Ozempic to lower Alzheimer's risk: Expert Clearing away snow and ...
The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...
Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...
For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.
Ozempic, Wegovy and Mounjaro may offer serious health benefits beyond weight loss. The GLP-1 medications have been linked to decreased risks of heart disease, kidney disease and Alzheimer’s ...